Combination of antagonist Biological activity of angiopoietin-2 and VEGF antagonist Biological activity and / or KDR and / or FLT1, Pharmaceutical compositions and applications

摘要

The Invention relates to agents with antiangiogenic activity and are therefore useful in Methods of treatment of Disease States associated with angiogenesis in the body of an animal or human being.More specifically, The Invention relates to a combination of an antagonist of the Biological activity of angiopoyetuna - 2 and an antagonist of the Biological activity of VEGF - and / or KDR and / or ft11, and to uses of such antagonists.